Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target

Benzinga Newsdesk www.benzinga.com Negative 95.5%

Neg 95.5% Neu 0% Pos 0%

Wedbush analyst Martin Fan reiterates ImageneBio (NASDAQ:IMA) with a Underperform and maintains $2 price target.

Comments

No comments yet. Be the first!